The role of antiglycolipid antibodies in peripheral neuropathies
- 1 October 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 13 (5) , 583-588
- https://doi.org/10.1097/00019052-200010000-00013
Abstract
The role of antiglycolipid antibodies in peripheral neuropathy continues to be defined in terms of clinical-serological associations and innovative experimental work establishing the role of these antibodies in pathogenesis. The present review focuses on the major developments in this field over the past 12 months.Keywords
This publication has 54 references indexed in Scilit:
- Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodiesNeurology, 1999
- The immunopathogenesis of Miller Fisher syndromeJournal of Neuroimmunology, 1999
- Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodiesJournal of the Neurological Sciences, 1999
- Hyperreflexia in Guillain-Barre syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibodyJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Autoantibodies associated with peripheral neuropathyMuscle & Nerve, 1999
- Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbanceAnnals of Neurology, 1999
- Facts and fallacies on anti-GM1 antibodies: physiology of motor neuropathies.Brain, 1999
- Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain–Barré syndrome after Campylobacter jejuni enteritisJournal of Neuroimmunology, 1999
- Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in ChinaJournal of the Neurological Sciences, 1999
- Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr syndromeAnnals of Neurology, 1999